A Study to Identify Risk Factors for 30-Day Readmission


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 18-003096
    Sponsor Protocol Number: 18-003096

About this study

The primary purpose of this study is to collect data on patient-identified factors which contribute to readmissions to the Mayo Clinic Hospital Medicine Services within 30 days of discharge.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Patients 18 years of age or older.
  • Adults who have been admitted to the Mayo Clinic Inpatient Medical services at Mayo Clinic Hospital-Rochester within 30 days of discharge from a prior hospitalization at Mayo Clinic Hospital-Rochester. 
  • Patients who are admitted as both inpatient and observation status will be eligible for participation in the study.

Exclusion Criteria: 

  • Patients under 18 years of age.
  • Patients who are admitted or readmitted to a hospital other than Mayo Clinic Hospital-Rochester will not be eligible.
  • Patients not admitted to an inpatient Medicine service at Mayo Clinic Hospital-Rochester will not be eligible.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Paul Robelia, M.D.

Open for enrollment

Contact information:

Paul Robelia M.D.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer